NA+- and K+-channels as molecular targets of the alkaloid ajmaline in skeletal muscle fibres

British Journal of Pharmacology
O FriedrichR H Fink

Abstract

Ajmaline is a widely used antiarrhythmic drug. Its action on voltage-gated ion channels in skeletal muscle is not well documented and we have here elucidated its effects on Na(+) and K(+) channels. Sodium (I(Na)) and potassium (I(K)) currents in amphibian skeletal muscle fibres were recorded using 'loose-patch' and two-microelectrode voltage clamp techniques (2-MVC). Action potentials were generated using current clamp. Under 'loose patch' clamp conditions, the IC(50) for I(Na) was 23.2 microM with Hill-coefficient h=1.21. For I(K), IC(50) was 9.2 microM, h=0.87. Clinically relevant ajmaline concentrations (1-3 microM) reduced peak I(Na) by approximately 5% but outward I(K) values were reduced by approximately 20%. Na(+) channel steady-state activation and fast inactivation were concentration-dependently shifted towards hyperpolarized potentials ( approximately 10 mV at 25 microM). Inactivation curves were markedly flattened by ajmaline. Peak-I(K) under maintained depolarisation was reduced to approximately 30% of control values by 100 microM ajmaline. I(K) activation time constants were increased at least two-fold. Lower concentrations (10 or 25 microM) reduced steady-state-I(K) slightly but peak-I(K) significantly. Action pot...Continue Reading

References

Aug 1, 1992·The Journal of Membrane Biology·Z Kra-OzH Meiri
Oct 1, 1992·Physiological Reviews·W A Catterall
Dec 1, 1992·British Journal of Pharmacology·H SakutaY Watanabe
May 1, 1991·Journal of Molecular and Cellular Cardiology·J L Alvarez, G Vassort
Apr 1, 1990·Anesthesiology·J F Butterworth, G R Strichartz
Jun 1, 1986·The Journal of General Physiology·J H CaldwellK G Beam
Aug 1, 1981·Pflügers Archiv : European journal of physiology·O P HamillF J Sigworth
Apr 1, 1983·The Journal of General Physiology·K G Beam, P L Donaldson
May 1, 1995·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·P K Stys
May 19, 1995·The Journal of Biological Chemistry·J C McPheeW A Catterall
Dec 6, 1994·Proceedings of the National Academy of Sciences of the United States of America·J C McPheeW A Catterall
Dec 5, 1995·Proceedings of the National Academy of Sciences of the United States of America·X YaoG V Desir
Dec 1, 1996·The Journal of General Physiology·L Q ChenR G Kallen
Oct 3, 1999·Physiological Reviews·F Lehmann-Horn, K Jurkat-Rott
Nov 22, 2000·Biochimie·S Cestèle, W A Catterall
May 17, 2001·Brain : a Journal of Neurology·J F DesaphyD C Camerino
Jun 18, 2004·Journal of Molecular Biology·Sarel J FleishmanNir Ben-Tal
Oct 2, 2004·The Journal of Physiology·M Oana PopaHolger Lerche
Dec 16, 2004·Naunyn-Schmiedeberg's Archives of Pharmacology·Claudia KieseckerJohann Kiehn

❮ Previous
Next ❯

Citations

Jul 9, 2013·Naunyn-Schmiedeberg's Archives of Pharmacology·F FischerE P Scholz
Dec 4, 2014·Phytochemistry·Nicolas J MartinPhila Raharivelomanana
Apr 24, 2012·Neurologia Medico-chirurgica·Satoru OsukaAkira Matsumura
Jul 3, 2015·Physiological Reviews·O FriedrichL Larsson
Mar 12, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sara E BassGrace Chao Yeh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.